- Pharming Announces European Medicines Agency (EMA) Validates its Marketing Authorisation Application under Accelerated Assessment for leniolisib
- Pharming submits a Marketing Authorisation Application to the European Medicines Agency for Leniolisib
- Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib
Pharming Group NV (PHGUF:PKL) closed at 1.10, -15.38% below its 52-week high of 1.30, set on Sep 09, 2022.
0.735May 12 20221.30Sep 09 2022
Markit short selling activity
|Market cap||765.75m EUR|
|EPS (TTM)||0.0412 |
Data delayed at least 15 minutes, as of Nov 07 2022.